- Delivery outcome in relation to maternal use of some recently introduced antidepressantsRoland Lennestål
Department of Clinical Pharmacology, Norrland University Hospital, Umea, Sweden
J Clin Psychopharmacol 27:607-13. 2007..We found no increased risk for stillbirths or congenital malformations. Delivery outcome after exposure to SNRI/NRI drugs resembles much what has been described after use of SSRI drugs. No signs of teratogenicity were found...